Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Expert Opinion on Therapeutic Targets
|
May 13, 2017
S100-alarmins: potential therapeutic targets for arthritis
Judith Austermann, Stefanie Zenker, Johannes Roth
Nature Reviews. Rheumatology
|
August 5, 2018
S100 proteins in rheumatic diseases
Judith Austermann, Christoph Spiekermann, Johannes Roth
Cells
|
June 24, 2022
The Good and the Bad: Monocytes' and Macrophages' Diverse Functions in Inflammation
Judith Austermann, Johannes Roth, Katarzyna Barczyk-Kahlert
The Journal of Biological Chemistry
|
August 30, 2008
Characterization of the Ca2+ -regulated ezrin-S100P interaction and its role in tumor cell migration
Judith Austermann, Ali Reza Nazmi, Carsten Müller-Tidow, et al.
FEBS Letters
|
December 8, 2004
Specific association of annexin 1 with plasma membrane-resident and internalized EGF receptors mediated through the protein core domain
Susanne Radke, Judith Austermann, Francoise Russo-Marie, et al.
Biochemistry
|
February 28, 2008
Actin binding of ezrin is activated by specific recognition of PIP2-functionalized lipid bilayers
Matthias Janke, Alexander Herrig, Judith Austermann, et al.
Biochemistry
|
October 25, 2006
Cooperative adsorption of ezrin on PIP2-containing membranes
Alexander Herrig, Matthias Janke, Judith Austermann, et al.
Biochimica Et Biophysica Acta
|
December 30, 2008
Generation and characterization of a novel, permanently active S100P mutant
Judith Austermann, Ali Reza Nazmi, Annika Heil, et al.
Biomedicines
|
March 29, 2023
S100A8/S100A9 Integrates F-Actin and Microtubule Dynamics to Prevent Uncontrolled Extravasation of Leukocytes
Marc Wolf, Robiya Joseph, Judith Austermann, et al.
The Journal of Biological Chemistry
|
December 24, 2010
S100P is a novel interaction partner and regulator of IQGAP1
Annika Heil, Ali Reza Nazmi, Max Koltzscher, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Expert Opinion on Therapeutic Targets
|
May 13, 2017
S100-alarmins: potential therapeutic targets for arthritis
Judith Austermann, Stefanie Zenker, Johannes Roth
Nature Reviews. Rheumatology
|
August 5, 2018
S100 proteins in rheumatic diseases
Judith Austermann, Christoph Spiekermann, Johannes Roth
Cells
|
June 24, 2022
The Good and the Bad: Monocytes' and Macrophages' Diverse Functions in Inflammation
Judith Austermann, Johannes Roth, Katarzyna Barczyk-Kahlert
The Journal of Biological Chemistry
|
August 30, 2008
Characterization of the Ca2+ -regulated ezrin-S100P interaction and its role in tumor cell migration
Judith Austermann, Ali Reza Nazmi, Carsten Müller-Tidow, et al.
FEBS Letters
|
December 8, 2004
Specific association of annexin 1 with plasma membrane-resident and internalized EGF receptors mediated through the protein core domain
Susanne Radke, Judith Austermann, Francoise Russo-Marie, et al.
Biochemistry
|
February 28, 2008
Actin binding of ezrin is activated by specific recognition of PIP2-functionalized lipid bilayers
Matthias Janke, Alexander Herrig, Judith Austermann, et al.
Biochemistry
|
October 25, 2006
Cooperative adsorption of ezrin on PIP2-containing membranes
Alexander Herrig, Matthias Janke, Judith Austermann, et al.
Biochimica Et Biophysica Acta
|
December 30, 2008
Generation and characterization of a novel, permanently active S100P mutant
Judith Austermann, Ali Reza Nazmi, Annika Heil, et al.
Biomedicines
|
March 29, 2023
S100A8/S100A9 Integrates F-Actin and Microtubule Dynamics to Prevent Uncontrolled Extravasation of Leukocytes
Marc Wolf, Robiya Joseph, Judith Austermann, et al.
The Journal of Biological Chemistry
|
December 24, 2010
S100P is a novel interaction partner and regulator of IQGAP1
Annika Heil, Ali Reza Nazmi, Max Koltzscher, et al.
Page
of 3